The percentage of CD4+ T cells were negatively correlated with Ann Arbor stage, IPI score, LDH, KI-67, and NEUT, implying that CD4+ T cell levels may play a crucial role in DLBCL progression, related infections, or treatment responses. This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.